Metraipolis › archive › dc_b301be9aac8a

Safety and Effectiveness of Insulin Degludec in Patients With Type 2 Diabetes Mellitus With Chronic Liver Disease — Europe PMC PMID:41798541

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41798541
DOI
10.7759/cureus.102882
License (as archived)
solo-consultazione
Archived
2026-11-06T04:16:40.766Z
SHA-256 of the archived text
eb9cf0ca190d18796cb90f0018a118b53db57b59811258225f1b33f22816254a
Stable URL of this page
https://metraipolis.com/documento/dc_b301be9aac8a

How to cite

Safety and Effectiveness of Insulin Degludec in Patients With Type 2 Diabetes Mellitus With Chronic Liver Disease — Europe PMC PMID:41798541 — Europe PMC (en), https://europepmc.org/article/MED/41798541 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b301be9aac8a (Metraipolis archive dc_b301be9aac8a, sha256 eb9cf0ca190d18796cb90f0018a118b53db57b59811258225f1b33f22816254a)
BibTeX
@misc{dcb301be9aac8a,
  title = {Safety and Effectiveness of Insulin Degludec in Patients With Type 2 Diabetes Mellitus With Chronic Liver Disease — Europe PMC PMID:41798541},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41798541},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b301be9aac8a; sha256 eb9cf0ca190d18796cb90f0018a118b53db57b59811258225f1b33f22816254a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41798541. Agents can read the archived copy with the MCP tool read_document.